Lynx Equity sees Apple stock supply shortages easing mid-2027

Lynx Equity expects Apple’s supply and pricing pressures to potentially peak in the December quarter, with shortages easing in mid-2027; its checks indicate bit supply could improve in the second half of 2027. Consensus revenue and iPhone revenue growth are each 6% year over year, down from Apple’s recent 14% overall revenue growth, and Lynx says December-quarter guidance could be worse. The firm’s longer-term outlook has improved, but it says the incoming CEO needs to outline supply milestones; Apple trades at $344.63, about 1% below its 52-week high.

Analysis

The key issue is whether constrained supply is merely deferring Apple demand or destroying it through high prices and longer waits. If shipments are being capped, reported revenue can understate underlying demand; but prior pull-forwards and inventory buffers also raise the risk of a post-quarter air pocket. The December-quarter mix matters: weaker units alongside elevated component costs could pressure gross margin even if pricing supports average selling prices.

Near term (days to weeks), the setup is asymmetric: expectations and the share price appear demanding relative to the cited slowdown, while the CEO’s first call must clarify both the quarter and the path beyond it. A favorable long-dated supply narrative is not a substitute for quantified milestones. Over 1–3 months, watch guidance, iPhone unit/shipment data, wait times and gross-margin commentary. Any supply relief in 2H27 is a 6–18 month thesis and may already be partly discounted. Component suppliers could benefit if improved availability converts deferred Apple orders into production, but that is conditional on demand holding up; don’t treat it as a confirmed supplier earnings catalyst.

Contrarian risk: a weak quarter may be a temporary supply constraint rather than demand deterioration, making an outright short vulnerable to a CEO-led expectations reset. Conversely, improving supply could expose demand elasticity at current pricing. South Korea’s regulatory action adds a separate, likely secondary risk; monitor for broader remedies rather than extrapolating one fine. The thesis is falsified by resilient unit growth and margins despite constraints, or by a credible supply timetable paired with stable demand; it strengthens on weaker guidance, margin compression, or falling wait times without shipment acceleration.

Key Decisions for Investors

• Avoid adding to AAPL ahead of the earnings/CEO call while the stock is near its high; treat the event as a catalyst, not a reason to chase.
• For existing long exposure, consider a defined-risk put spread or reduce position size through the event. Keep the hedge tactical: an explicit supply-and-margin recovery plan could trigger a sharp relief move.
• Reassess after the call using December-quarter guidance, gross-margin trajectory, iPhone shipment/unit indicators and concrete 2027 supply milestones. Do not underwrite the longer-term thesis on an unquantified improvement claim.
• Watch component suppliers only as a conditional follow-through trade: require evidence that improved availability is translating into Apple production and orders, not just broader industry supply.